Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Talis Biomedical Corporation (TLIS) stock

Learn how to easily invest in Talis Biomedical Corporation stock.

Talis Biomedical Corporation
NASDAQ: TLIS - USD
MEDICAL DEVICES
$11.70
+$0.01 (+0.09%)

Talis Biomedical Corporation is a medical devices business based in the US. Talis Biomedical Corporation shares (TLIS) are listed on the NASDAQ and all prices are listed in US Dollars. Talis Biomedical Corporation employs 133 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Talis Biomedical Corporation

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – TLIS – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Talis Biomedical Corporation stock price (NASDAQ: TLIS)

Use our graph to track the performance of TLIS stocks over time.

Talis Biomedical Corporation shares at a glance

Information last updated 2021-07-15.
Latest market close$10.05
52-week range$9.43 - $33.90
50-day moving average $10.43
200-day moving average $12.92
Wall St. target price$14.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) N/A

Buy Talis Biomedical Corporation shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $3.00 and $300 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
Download and sign up with Public.com; approved accounts receive a free stock slice worth up to $70, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
Robinhood
$0
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Moomoo
$0 for US stocks
Stocks, Options, ETFs
$0
$0 per year
N/A
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Talis Biomedical Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Talis Biomedical Corporation price performance over time

Historical closes compared with the close of $10.05 from 2021-06-08

1 week (2021-07-13) N/A
1 month (2021-06-24) -8.47%
3 months (2021-04-20) N/A
6 months (2021-01-20) N/A
1 year (2020-07-20) N/A
2 years (2019-07-20) N/A
3 years (2018-07-20) N/A
5 years (2016-07-20) N/A

Talis Biomedical Corporation financials

Revenue TTM $17.5 million
Gross profit TTM $-76,601,000
Return on assets TTM -50.85%
Return on equity TTM -89.35%
Profit margin 0%
Book value N/A
Market capitalisation $249.5 million

TTM: trailing 12 months

Shorting Talis Biomedical Corporation shares

There are currently 2.1 million Talis Biomedical Corporation shares held short by investors – that's known as Talis Biomedical Corporation's "short interest". This figure is 0.5% up from 2.0 million last month.

There are a few different ways that this level of interest in shorting Talis Biomedical Corporation shares can be evaluated.

Talis Biomedical Corporation's "short interest ratio" (SIR)

Talis Biomedical Corporation's "short interest ratio" (SIR) is the quantity of Talis Biomedical Corporation shares currently shorted divided by the average quantity of Talis Biomedical Corporation shares traded daily (recently around 381777.92207792). Talis Biomedical Corporation's SIR currently stands at 5.39. In other words for every 100,000 Talis Biomedical Corporation shares traded daily on the market, roughly 5390 shares are currently held short.

To gain some more context, you can compare Talis Biomedical Corporation's short interest ratio against those of similar companies.

However Talis Biomedical Corporation's short interest can also be evaluated against the total number of Talis Biomedical Corporation shares, or, against the total number of tradable Talis Biomedical Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Talis Biomedical Corporation's short interest could be expressed as 0.07% of the outstanding shares (for every 100,000 Talis Biomedical Corporation shares in existence, roughly 70 shares are currently held short) or 0.2288% of the tradable shares (for every 100,000 tradable Talis Biomedical Corporation shares, roughly 229 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Talis Biomedical Corporation.

Find out more about how you can short Talis Biomedical Corporation stock.

Talis Biomedical Corporation share dividends

We're not expecting Talis Biomedical Corporation to pay a dividend over the next 12 months.

Talis Biomedical Corporation overview

Talis Biomedical Corporation operates as a molecular diagnostic company. It is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. The company is also developing Talis One assay kits for respiratory infections, infections related to women's health, and sexually transmitted infections; and other tests for the detection of other respiratory infections, such as a respiratory panel test to detect influenza A and influenza B plus SARS-CoV-2. Talis Biomedical Corporation was incorporated in 2013 and is headquartered in Menlo Park, California. .

Frequently asked questions

What percentage of Talis Biomedical Corporation is owned by insiders or institutions?
Currently 1.753% of Talis Biomedical Corporation shares are held by insiders and 81.998% by institutions.
How many people work for Talis Biomedical Corporation?
Latest data suggests 133 work at Talis Biomedical Corporation.
When does the fiscal year end for Talis Biomedical Corporation?
Talis Biomedical Corporation's fiscal year ends in December.
Where is Talis Biomedical Corporation based?
Talis Biomedical Corporation's address is: 230 Constitution Drive, Menlo Park, CA, United States, 94025

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site